Commonly used surfactant, Tween 80, improves absorption of P-glycoprotein substrate, digoxin, in rats
暂无分享,去创建一个
Ming Yao | Richard A. Morrison | S. Chong | R. Morrison | Hongjiang Zhang | M. Yao | Hongjian Zhang | Saeho Chong
[1] Y. Tanigawara. Role of P-glycoprotein in drug disposition. , 2000, Therapeutic drug monitoring.
[2] P. Hinderling,et al. Pharmacokinetics of Digoxin and Main Metabolites/Derivatives in Healthy Humans , 1991, Therapeutic drug monitoring.
[3] Leslie Z. Benet,et al. Effects of Ketoconazole on Digoxin Absorption and Disposition in Rat , 1998, Pharmacology.
[4] J. Hochman,et al. In vitro substrate identification studies for p-glycoprotein-mediated transport: species difference and predictability of in vivo results. , 2001, The Journal of pharmacology and experimental therapeutics.
[5] I. Pastan,et al. Biochemistry of multidrug resistance mediated by the multidrug transporter. , 1993, Annual review of biochemistry.
[6] S. Chong,et al. A rapid and sensitive LC/MS/MS assay for quantitative determination of digoxin in rat plasma. , 2003, Journal of pharmaceutical and biomedical analysis.
[7] M. Polymeropoulos,et al. Cytogenetic and molecular characterization of random chromosomal rearrangements activating the drug resistance gene, MDR1/P‐glycoprotein, in drug‐selected cell lines and patients with drug refractory ALL , 1998, Genes, chromosomes & cancer.
[8] G R Wilkinson,et al. Inhibition of P-glycoprotein-mediated drug transport: A unifying mechanism to explain the interaction between digoxin and quinidine [seecomments]. , 1999, Circulation.
[9] R. Borchardt,et al. Mechanistic roles of neutral surfactants on concurrent polarized and passive membrane transport of a model peptide in Caco-2 cells. , 1997, Journal of pharmaceutical sciences.
[10] Ronald T Borchardt,et al. A comparison of commonly used polyethoxylated pharmaceutical excipients on their ability to inhibit P-glycoprotein activity in vitro. , 2002, Journal of pharmaceutical sciences.
[11] A. D. Rodrigues,et al. Drug-drug interactions , 2001, Atkinson's Principles of Clinical Pharmacology.
[12] Y. Sugiyama,et al. Effect of PSC 833, a P-glycoprotein modulator, on the disposition of vincristine and digoxin in rats. , 1999, Drug metabolism and disposition: the biological fate of chemicals.
[13] J. Schellens,et al. P-glycoprotein system as a determinant of drug interactions: the case of digoxin-verapamil. , 1999, Pharmacological research.
[14] Alexander V. Kabanov,et al. Effects of Pluronic Block Copolymers on Drug Absorption in Caco-2 Cell Monolayers , 1998, Pharmaceutical Research.
[15] J. Silverman. Multidrug-resistance transporters. , 1999, Pharmaceutical biotechnology.
[16] L. Benet,et al. Metabolism of digoxin and digoxigenin digitoxosides in rat liver microsomes: involvement of cytochrome P4503A. , 1999, Xenobiotica; the fate of foreign compounds in biological systems.
[17] Alex Sparreboom,et al. Role of Formulation Vehicles in Taxane Pharmacology , 2001, Investigational New Drugs.
[18] M. Kool,et al. The multidrug resistance protein family. , 1999, Biochimica et biophysica acta.
[19] T. Druley,et al. From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance , 2001, Cellular and Molecular Life Sciences CMLS.
[20] E. Iisalo. Clinical Pharmacokinetics of Digoxin , 1977, Clinical pharmacokinetics.
[21] J. Schellens,et al. The co-solvent Cremophor EL limits absorption of orally administered paclitaxel in cancer patients , 2001, British Journal of Cancer.
[22] G. Houin,et al. Effect of Polyoxyl 35 Castor Oil and Polysorbate 80 on the Intestinal Absorption of Digoxin in vitro , 2000, Arzneimittelforschung.
[23] M Rowland,et al. Kinetic profiling of P-glycoprotein-mediated drug efflux in rat and human intestinal epithelia. , 2001, The Journal of pharmacology and experimental therapeutics.
[24] B. Angelin,et al. Interactions in the renal and biliary elimination of digoxin: Stereoselective difference between quinine and quinidine , 1990, Clinical pharmacology and therapeutics.